0000899243-23-018119.txt : 20230814 0000899243-23-018119.hdr.sgml : 20230814 20230814171345 ACCESSION NUMBER: 0000899243-23-018119 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230811 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boston Megan CENTRAL INDEX KEY: 0001808923 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39267 FILM NUMBER: 231171955 MAIL ADDRESS: STREET 1: LEVEL 14, 114 WILLIAM ST CITY: MELBOURNE, VIC STATE: C3 ZIP: 3000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Benitec Biopharma Inc. CENTRAL INDEX KEY: 0001808898 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3940 TRUST WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: (510) 780-0819 MAIL ADDRESS: STREET 1: 3940 TRUST WAY CITY: HAYWARD STATE: CA ZIP: 94545 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-08-11 0 0001808898 Benitec Biopharma Inc. BNTC 0001808923 Boston Megan C/O BENITEC BIOPHARMA INC. 3940 TRUST WAY HAYWARD CA 94545 1 1 0 0 Executive Director 0 Common Stock 2023-08-11 4 P 0 25907 A 25907 D Common Stock 20 I By Boston Super Invest Pty A/C Boston Family Super Common Warrants (right to buy) 3.86 2023-08-11 4 P 0 25907 A 2023-08-11 2028-08-11 Common Stock 25907 25907 D Represents shares of common stock, par value $0.0001 per share (the "Common Stock") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93. The reported number of shares has been adjusted to reflect the impact of the Issuer's 17-for-1 reverse stock split completed on July 26, 2023. /s/ Megan Boston 2023-08-14